Julia Newman
PrEP-ception: Using PrEP to Reduce HIV Transmission Risk During Conception
By Julia Newman
|
May 1, 2014
|
Comments Off on PrEP-ception: Using PrEP to Reduce HIV Transmission Risk During Conception
We don’t have a cure for AIDS yet, but, in 2012, the Food and Drug Administration (FDA) approved daily use of Truvada (an anti-retroviral drug combination containing tenofovir and emtricitabine) for “Pre-Exposure Prophylaxis (PrEP)” to reduce the risk of HIV transmission during sexual intercourse.